Project Number PTCG-21-818270 Agency/Funding Organization Alzheimer's Association Funding Year 2021 View Full Project Details for Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in FTLD-TDP Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator Peter Ljubenkov Principal Investigator Peter Ljubenkov Awardee Organization The Regents of the University of California, University of California, San Francisco Awardee State California Contact PI Country United States Project Detail FY Overall Cost $2,657,600 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Alzheimer's Association
